Imovax Polio

Imovax Polio: Vaccine against polio

Imovax Polio is a vaccine developed and produced by the pharmaceutical company Pasteur Merrier Connaught in France. It belongs to the pharmaceutical group of vaccines and is intended to prevent polio.

Polio, also known as infantile paralysis, is caused by the polio virus, which attacks the nervous system and can lead to paralysis. This infectious disease is transmitted through the fecal-oral route, most often through contaminated drinking water or food. Polio can have serious consequences, especially for children, and can be fatal in some cases.

Imovax Polio offers protection against the three main types of polio virus: type 1, type 2 and type 3. The vaccine contains the viruses in an inactivated (killed) form, which means they are not capable of causing disease, but help develop the body's immunity to the virus.

Imovax Polio is available in several dosage forms, including a solution for subcutaneous injection and a solution for intramuscular injection. The vaccine is recommended for use in children and adults.

The Imovax Polio vaccination process usually involves multiple doses, which are given at specific intervals. Full vaccination can provide long-term immunity from polio.

The Imovax Polio vaccine has a good safety profile and is generally well tolerated by patients. However, as with any medication, unwanted effects are possible. The most common side effects may include mild redness or soreness at the injection site.

Overall, Imovax Polio is an effective and safe vaccine that helps prevent polio. Regular vaccination helps create herd immunity in society and reduces the risk of the occurrence and spread of polio.

It is important to note that for complete information about the Imovax Polio vaccine, its use and possible side effects, you should contact your healthcare professional or consult your local health authority.